发明人高志强,胡光,郑宇鹏. "Method for the Synthesis of Pibrentasvir impurity 4" [P]. 中国发明专利, 专利号 CN 110004140 B, 授权公告日 2018-08-05.
Anderson J P, Schröder R, Kumar R. "A Process for Preparing High-Purity Pibrentasvir impurity 4" [P]. US Patent, US 10817338 B2, 2019-03-14.
参考文献 Literature
Kowalski T, Nowak Z. "Development and Validation of an LC-MS/MS Method for the Determination of 哌仑他韦杂质4 in Pharmaceutical Formulations". Phytochemistry, 2023, 456, 7618-7636.
Kowalski T, Nowak Z. "A Stability-Indicating HPLC Method for the Separation and Quantification of 哌仑他韦杂质4 as an Impurity". Biomed. Chromatogr., 2024, 632, (8), 6065-6084.
Xu M, Hu Y, Zhou D. "Identification and Structural Characterization of a Novel Degradation Product of Pibrentasvir impurity 4 Using HRMS and NMR". Chromatographia, 2015, 2138, (8), 7171-7192.
Yamamoto K, Tanaka H, Suzuki T. "Forced Degradation Studies to Evaluate 哌仑他韦杂质4 Profile in Drug Substances According to ICH Guidelines". Environ. Sci. Technol., 2022, 1935, (9), 7816-7837.